In this episode of the Ultimate Dental Podcast, Dr. David Moffet interviews Owen Morgan, CEO of Bioanalytics, about their innovative iSplr device [pronounced “I-sleeper”] aimed at treating sleep apnoea, particularly for patients who cannot tolerate traditional CPAP machines.They discuss the significant impact of sleep disorders on health and the economy, the advancements in dental technology, and the importance of dentists in addressing sleep-related issues.Owen shares insights on the regulatory journey of their product, and its potential to improve patient care and quality of life.What you will learn:[01:20 ] Introduction to Bioanalytics and Sleep Apnoea[03:16 ] The Impact of Sleep Apnoea on Health[05:33 ] The Role of Dentists in Treating Sleep Disorders[08:17 ] Challenges with Current Sleep Apnoea Treatments[14:11 ] Introducing the Bioanalytics Device the iSplr[16:51 ] Innovations in Sleep Apnoea Treatment[24:09 ] Regulatory Approvals and Market Readiness[25:47 ] Future Plans for Bioanalytics[34:08 ] Conclusion and Call to ActionTakeaways Bioanalytics is revolutionising healthcare with innovative devices. Sleep apnoea affects millions and is linked to serious health issues. Many patients struggle with CPAP machines, leading to non- compliance. Dentists have a unique opportunity to address sleep disorders. The economic burden of sleep apnoea is significant, costing billions annually. The Bioanalytics iSplr device [pronounced “I-sleeper”] is adjustable and mass-produced for accessibility. Regulatory approvals are crucial for market entry and credibility. The iSplr device offers both therapeutic and diagnostic capabilities. Investing in sleep health can lead to better patient outcomes. Dentists can enhance their practice by integrating sleep medicine into their services.Sound Bites "This device is quite a number." "Not everyone could tolerate CPAP." "It's a huge burden on our economy."